| Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 535.00 k | 535.00 k | 535.00 k | 535.00 k | 535.00 k | 535.00 k |
| Cash burn (monthly) | (no burn) | 216.50 k | 289.67 k | 73.58 k | 327.67 k | 1.49 mm |
| Cash used (since last report) | n/a | 3.70 mm | 4.95 mm | 1.26 mm | 5.60 mm | 25.46 mm |
| Cash remaining | n/a | -3.16 mm | -4.41 mm | -721.96 k | -5.06 mm | -24.92 mm |
| Runway (months of cash) | n/a | -14.6 | -15.2 | -9.8 | -15.4 | -16.7 |
| 13F holders | Current |
|---|---|
| Total holders | 4 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 6.25 mm |
| Total shares | 9.20 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Cystic Fibrosis Foundation | 5.17 mm | $5.12 mm |
| Lind Global Fund II | 3.00 mm | $1.13 mm |
| AZN AstraZeneca | 884.96 k | $0.00 |
| Francis Capital Management | 142.84 k | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Jun 24 | Hasan Jafri | Stock options Common Stock | Grant | Acquire A | No | No | 0.063 | 250,000 | 15.75 k | 382,495 |
| 27 Jun 24 | Susan Richards Windham-Bannister | Stock options Common Stock | Grant | Acquire A | No | No | 0.063 | 200,000 | 12.60 k | 261,000 |
| 27 Jun 24 | John F Hamilton | Stock options Common Stock | Grant | Acquire A | No | No | 0.063 | 200,000 | 12.60 k | 269,040 |
| 24 Jun 24 | Vu Truong | Common stock purchase | Buy | Acquire P | No | No | 0.07 | 714,286 | 50.00 k | 1,378,639 |
| 24 Jun 24 | Eric Patzer | Common stock purchase | Buy | Acquire P | No | No | 0.07 | 714,286 | 50.00 k | 884,600 |
